🇺🇸 FDA
Patent

US 8067439

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P1/06A61P1/12

Quick answer

US patent 8067439 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/06, A61P1/12, A61P11/00, A61P11/02